NTRK1 and congenital fibrosarcoma: Increased phosphorylation levels of the fusion protein upon expression of lmna-ntrk1 fusion construct in congenital fibrosarcoma cells provide a novel avenue for treatment in congenital fibrosarcoma patients (Wiesner et al., 2014).